Tejaswini Appidi

498 total citations
21 papers, 361 citations indexed

About

Tejaswini Appidi is a scholar working on Biomedical Engineering, Materials Chemistry and Electronic, Optical and Magnetic Materials. According to data from OpenAlex, Tejaswini Appidi has authored 21 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biomedical Engineering, 8 papers in Materials Chemistry and 7 papers in Electronic, Optical and Magnetic Materials. Recurrent topics in Tejaswini Appidi's work include Nanoplatforms for cancer theranostics (10 papers), Gold and Silver Nanoparticles Synthesis and Applications (7 papers) and Nanoparticle-Based Drug Delivery (5 papers). Tejaswini Appidi is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Gold and Silver Nanoparticles Synthesis and Applications (7 papers) and Nanoparticle-Based Drug Delivery (5 papers). Tejaswini Appidi collaborates with scholars based in India, United States and France. Tejaswini Appidi's co-authors include Aravind Kumar Rengan, Rohit Srivastava, Deepak B. Pemmaraju, Nooruddin Khan, Hui‐Fen Wu, Gangaraju Gedda, Krishna Kanthi Gudimella, Mahadeb Pal, Gillipsie Minhas and Surya Prakash Singh and has published in prestigious journals such as Nanoscale, Molecular Cancer and International Journal of Biological Macromolecules.

In The Last Decade

Tejaswini Appidi

18 papers receiving 353 citations

Peers

Tejaswini Appidi
Tejaswini Appidi
Citations per year, relative to Tejaswini Appidi Tejaswini Appidi (= 1×) peers Agata Zauszkiewicz–Pawlak

Countries citing papers authored by Tejaswini Appidi

Since Specialization
Citations

This map shows the geographic impact of Tejaswini Appidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tejaswini Appidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tejaswini Appidi more than expected).

Fields of papers citing papers by Tejaswini Appidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tejaswini Appidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tejaswini Appidi. The network helps show where Tejaswini Appidi may publish in the future.

Co-authorship network of co-authors of Tejaswini Appidi

This figure shows the co-authorship network connecting the top 25 collaborators of Tejaswini Appidi. A scholar is included among the top collaborators of Tejaswini Appidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tejaswini Appidi. Tejaswini Appidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanan, Yogita, et al.. (2026). A gel-forming antioxidant eye drop for photoreceptor protection in retinitis pigmentosa. Drug Delivery and Translational Research. 16(4). 1052–1063.
2.
Appidi, Tejaswini, Michèle Moreau, Esteban Velarde, et al.. (2025). Engineered multifunctional nanoparticles for enhanced radiation therapy: three-in-one approach for cancer treatment. Molecular Cancer. 24(1). 68–68. 7 indexed citations
3.
Appidi, Tejaswini, Emmanuel Petit, Redouan Elboutachfaiti, et al.. (2025). Bioactive collagen peptide functionalized polyglucuronic acid - In vitro analysis as a potential biomaterial for bone tissue engineering. International Journal of Biological Macromolecules. 319(Pt 4). 145735–145735.
4.
Appidi, Tejaswini, et al.. (2024). A lipo-polymeric hybrid nanosystem with metal enhanced fluorescence for targeted imaging of metastatic breast cancer. Nanotheranostics. 8(2). 239–246. 5 indexed citations
5.
Appidi, Tejaswini, et al.. (2023). Development of a Point-of-Care Cervico-Vaginal Sampling/Testing Device for the Colorimetric Detection of Cervical Cancer. Diagnostics. 13(8). 1382–1382. 1 indexed citations
7.
Appidi, Tejaswini, et al.. (2022). Casein nanoformulations - Potential biomaterials in theranostics. Food Bioscience. 50. 102200–102200. 19 indexed citations
8.
Appidi, Tejaswini, et al.. (2021). Microfluidic design of tumor vasculature and nanoparticle uptake by cancer cells. Microfluidics and Nanofluidics. 25(5). 5 indexed citations
9.
Appidi, Tejaswini, et al.. (2021). The role played by bacterial infections in the onset and metastasis of cancer. Current Research in Microbial Sciences. 2. 100078–100078. 25 indexed citations
10.
Singh, Surya Prakash, Tejaswini Appidi, & Aravind Kumar Rengan. (2021). Biodegradable/disintegrable nanohybrids for photothermal theranostics. Proceedings of the Indian National Science Academy. 87(1). 94–106. 2 indexed citations
11.
Appidi, Tejaswini, et al.. (2021). Highly fluorescent polyethylene glycol-ascorbic acid complex for imaging and antimicrobial therapeutics. Materials Today Communications. 29. 102987–102987. 4 indexed citations
12.
Appidi, Tejaswini, et al.. (2020). Facile Synthesis of Fluorescent Polymer Encapsulated Metal (PoeM) Nanoparticles for Imaging and Therapeutic Applications. ACS Applied Polymer Materials. 2(3). 1388–1397. 19 indexed citations
13.
Gudimella, Krishna Kanthi, et al.. (2020). Sand bath assisted green synthesis of carbon dots from citrus fruit peels for free radical scavenging and cell imaging. Colloids and Surfaces B Biointerfaces. 197. 111362–111362. 84 indexed citations
14.
Appidi, Tejaswini, et al.. (2020). Development of label-free gold nanoparticle based rapid colorimetric assay for clinical/point-of-care screening of cervical cancer. Nanoscale Advances. 2(12). 5737–5745. 17 indexed citations
15.
Appidi, Tejaswini, Deepak B. Pemmaraju, Syed Baseeruddin Alvi, et al.. (2019). Light-triggered selective ROS-dependent autophagy by bioactive nanoliposomes for efficient cancer theranostics. Nanoscale. 12(3). 2028–2039. 45 indexed citations
16.
Alvi, Syed Baseeruddin, Tejaswini Appidi, Deepak B. Pemmaraju, et al.. (2019). The “nano to micro” transition of hydrophobic curcumin crystals leading to in situ adjuvant depots for Au-liposome nanoparticle mediated enhanced photothermal therapy. Biomaterials Science. 7(9). 3866–3875. 41 indexed citations
17.
Pemmaraju, Deepak B., Tejaswini Appidi, & Aravind Kumar Rengan. (2019). Photothermal Therapy Assisted Bioactive Nanoprobes for Effective Cancer Theranostics. 1–4. 1 indexed citations
18.
Appidi, Tejaswini, Rohit Srivastava, & Aravind Kumar Rengan. (2019). Optical Properties of Plasmonic Gold: A Possible Application for Screening of Cervical Cancer. 1–4. 2 indexed citations
19.
Shanavas, Asifkhan, Aravind Kumar Rengan, Deepak S. Chauhan, et al.. (2017). Glycol chitosan assisted in situ reduction of gold on polymeric template for anti-cancer theranostics. International Journal of Biological Macromolecules. 110. 392–398. 14 indexed citations
20.
Pemmaraju, Deepak B., Tejaswini Appidi, Gillipsie Minhas, et al.. (2017). Chlorophyll rich biomolecular fraction of A. cadamba loaded into polymeric nanosystem coupled with Photothermal Therapy: A synergistic approach for cancer theranostics. International Journal of Biological Macromolecules. 110. 383–391. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026